University of California San Francisco

Rita Mukhtar, MD

Biography

Dr. Rita Mukhtar specializes in breast surgery and general surgery for urgent conditions. For her patients with breast cancer, she offers expertise in total skin-sparing mastectomies, breast conservation, wire localization surgery (used to show the location of tissue requiring biopsy) and sentinel lymph node biopsy (used to see if cancer has spread).

Dr. Mukhtar's research program focuses on invasive lobular carcinoma, the second most common type of breast cancer. This work is funded by the American Cancer Society and the National Cancer Institute. She teaches medical students and residents, and serves as an Associate Program Director for the UCSF General Surgery Residency.

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2018
University of California, San Francisco M.D. Medicine 2006

Board Certifications

American Board of Surgery, General Surgery

Clinical Expertise

Breast Surgery

Lumpectomy

Seed and wire localization surgery

Nipple sparing/total skin sparing mastectomy

Sentinel lymph node biopsy

Axillary dissection

Emergency General Surgery

Program Affiliations

Carol Franc Buck Breast Care Center

Research Pathways

Clinical Discovery & Health Services Research

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy.
    Switalla KM, Onishi N, Jones EF, Lawhn-Heath C, Ray KM, Hathi DK, Carmona-Bozo JC, Metanat P, Lopes AJ, Falade IO, Quirarte A, Gottipati S, Guo R, Molina-Vega J, Pullakhandam K, Bareng TJ, Watkins M, Chien AJ, Joe BN, Esserman LJ, Hylton N, Mukhtar RA| | PubMed
  2. Tailoring Management for Invasive Lobular Carcinoma: Imaging, Surgical Treatment, and Systemic Therapy Considerations.
    Mukhtar RA, Covington MF, Fanucci K, Jeselsohn R| | PubMed
  3. Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.
    Corso G, Andreon C, La Vecchia C, Bottazzoli EI, Abruzzese G, Favilla K, Citterio O, Spoldi E, Di Silvestre S, De Scalzi AM, Polizzi A, Meduri E, Trapani D, Nicosia L, Pesapane F, Bossi D, Brogi E, Shen S, Mukhtar R, Criscitiello C, Veronesi P, Gandini S, Magnoni F, Curigliano G| | PubMed
  4. Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue.
    Goldhammer N, Bont M, Warhadpande S, Choi M, Cedano J, Greenwood H, Ye J, Schwartz CJ, Alvarado M, Ewing C, Goodwin K, Mukhtar RA, Wong J, Abe SE, Chandler J, Jackson J, Olopade OI, Campbell MJ, Lam A, Park C, Vertido A, van 't Veer LJ, Hylton N, Esserman LJ, Rosenbluth JM| | PubMed
  5. Locoregional Considerations for Invasive Lobular Carcinoma.
    Mukhtar RA, Flanagan MR| | PubMed
  6. Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast.
    Kaur M, Quirarte A, Vertido A, Torosian T, Li TM, Mouabbi JA, Mukhtar RA| | PubMed
  7. Cryoablation Versus Breast-Conserving Surgery for Early-Stage, Low-Risk Breast Cancer ≤ 1.5 cm: A Cost-Effectiveness Analysis.
    Wu X, Kolli KP, Mukhtar RA, Chung M, Joe BN, Kohlbrenner RM| | PubMed
  8. FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ.
    Ye J, Goldhammer N, Vohra P, Warhadpande S, de Castro GC, Rodas CKM, Moasser MM, Ramalingam K, Abe SE, Alvarado M, Ewing C, Goodwin KM, Mukhtar RA, Wong JM, Esserman LJ, Balassanian R, Rosenbluth JM| | PubMed
  9. ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Rita A. Mukhtar, Katrina Dimitroff, Christina Yau, A. Jo Chien, Eileen P. Connolly, Marissa Howard-McNatt, Roshni Rao, Velle Ladores, Mehra Golshan, Candice A. Sauder, Kamran Ahmed, Rachael Lancaster, Jana Fox, Lily Gutnik, M. Catherine Lee, Julia Tchou, Nicolas Prionas, Cletus A. Arciero, Chantal Reyna, Henry Kuerer, Kayla Switalla, Neil Taunk, Todd M. Tuttle, Meena S. Moran, Lauren M. Postlewait, Jane Perlmutter, Angela DeMichele, Douglas Yee, Nola Hylton, W. Fraser Symmans, Hope S. Rugo, Rebecca Shatsky, Claudine Isaacs, Laura J. Esserman, Laura van ‘t Veer, Judy C. Boughey| | UCSF Research Profile
  10. Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
    Van Hassel J, Dimitroff K, Yau C, Mukhtar R, Boughey JC, Ladores V, Howard-McNatt MM, Jaskowiak N, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Veer LV, Rugo H, Esserman LJ, Shatsky R, Isaacs C, Kuerer H, Wallace AM, Prionas N, Tseng J, Reyna CR, Taunk N, Kesmodel S, Lee MC, Fox J, Piltin MA, Tchou J, Arciero CA, Postlewait LM, Sauder C, Rao R| | PubMed